African histoplasmosis: Therapeutic efficacy of itraconazole

Journal of the European Academy of Dermatology and Venereology

Volumn 10, Issue 1, 1998, Pages 77-80

  Velho, G C ^a   Cabral, J M ^a   Massa, A ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

African histoplasmosis; Gynecomasty; Itraconazole; Ketoconazole

Indexed keywords

ITRACONAZOLE;

ADULT; CASE REPORT; CONFERENCE PAPER; DRUG EFFICACY; FUNGUS IDENTIFICATION; GYNECOMASTIA; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; MALE; PRIORITY JOURNAL; SKIN BIOPSY;

ANTIFUNGAL AGENTS; HISTOPLASMOSIS; HUMANS; ITRACONAZOLE; KETOCONAZOLE; MALE; MIDDLE AGED;

EID: 0031910206     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00097-4     Document Type: Conference Paper

References (30)

1. Drouhet E. Histoplasmosis. In: El-Sheikh Mahgoub, ed. Tropical Mycosis, Chapter 7. Beerse, Belgium: Janssen Research Council, 1989;115-147.
2. Hay RJ, Roberts SOB, Makenzie DWR. Mycology. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, 5th edn., vol. 2. Oxford: Blackwell Scientific Publications, 1992;1200-1202.
3. Shadomy HJ, Utz JP. Deep fungal infections. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine, 4th edn., vol. 2. New York: McGraw-Hill, 1993; 2477-2479.
4. Sobral FC. Histoplasmose Africana. Derm Ibero Lat Amer, 1969;XI(2):129-164.
5. Costa RBC, Corte-Real R, Pereira AS et al. Histoplasmose disseminada atípica. Rev Port D Infec 1985(a);8(1-4):113-117.
6. Camno G, Graça AS, Leal DS et al. Histoplasmose africana disseminada. A propósito de um caso clínico. Rev Port D Infec 1985(b);8(1-4):105-112.
7. Juminer B, Raccurt CP, Roudier M. Histoplasmose disséminée cher un malade guadeloupéen atteint de SIDA. Rôle révelateur des localisations cutanées. Nouv Dermatol 1991;10:472-476.
8. Faust H, Treadwell P. Cutaneous Histoplasma capsulatum in a non-immunocompromised patient with previously treated cutaneous Mycobacterium kansaii. J Am Acad Dermatol 1991;25:418-422.
9. Graybill JR, Sharkey PK. Fungal infections and their management. Br J Clin Pract 1990;44(9)(Suppl 71):23-31.
10. Negroni R, Palmieri O, Koren F et al. Oral treatment of Paracoccidioidomycosis and Histoplasmosis with itraconazole in humans. Rev Infect Dis 1987;9(Suppl 1):S47-S50.
11. Youle, et al. Histoplasmosis in a UK patient treated with itraconazole. AIDS 1990;4(6):602-603.
12. Marichal SM, Olanto SM, Gutiérrez JCG et al. Tratamiento exitoso de un caso de histoplasmosis africana con miconazol (Daktarin). Rev Cub Med Trop 1986;38(3):323-329.
13. Ajayi BGK, Osuntokun B, Olurin O et al. Orbital histoplasmosis due to Histoplasma capsulatum var. duboisii: successful treatment with septrim. J Trop Med Hyg 1986;89:179-187.
14. Mabey DCW, Ajdukiewicz AB, Hay RJ. Treatment of African histoplasmosis with itraconazole. Trans R Soc Trop Med Hyg 1983;77(2):219-220.
15. Lesbordes JL, Beuzit Y. Observation d'une histoplasmose a 'Histoplasma duboisii' traitée par le kétoconazole a Bangui (RCA). Med Trop 1986;46(3):303-303.
16. Lewis JH, Zimmerman HJ, Benson GD, Ishak KG. Hepatic injury associated with ketoconazole therapy. Gastroenterology 1984;86:503.
17. Pont A, Graybill JR, Graven PC et al. High dose ketoconazole and adrenal and testicular function in man. Arch Intern Med 1984;144:2150.
18. Tuckee WS, Snell BB, Gregg DP. Reversible adrenal insufficiency induced by ketoconazole. J Am Med Assoc 1985; 253:2413.
19. Nougué J, Nougué-Channarond M, Barousse C, Guillet G. Le ketoconazole a-t-il un effect antiandrogéne retardé? Ann Dermatol Venereol 1985;112:665-666.
20. Cutsem JV. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy. Br J Clin Pract 1990;44(9)(Suppl 71):32-40.
21. Cauwenbergh G, Doncker PD. Itraconazole (R51211): a clinical review of its antimicotic activity in dermatology, gynaecology and internal medicine. Drug Dev Res 1986;8:317-323.
22. Phillips P, Fetchick R, Weisman I et al. Tolerance and efficacy of itraconazole in treatment of systemic mycosis: preliminary results. Rev Infect Dis 1987;9(Suppl 1): S87-S93.
23. Cauwenbergh G, Legendre R, Blatchford N. Itraconazole, a novel oral antifungal: its efficacy and safety profile. 8th Reg Conf Dermatol, Bali, Indonesia 1988, part 1, 86-98.
24. Saag M, Bradsher R, Chapman S. The NIAID Mycoses Study Group. Itraconazole (I) therapy (Rx) for blastomycosis (B), histoplasmosis (H), and sporotrichosis (S). 28th Intersci Conf Antimicrob Agen Chemother, Los Angeles, California 1988; Abstr 574.
25. Dismukes W, Bradsher R, Girard W et al. The NIAID Mycosis Study Group. Itraconazole therapy for blastomycosis and histoplasmosis. 26th Intersci Conf Antimicrob Agents Chemother, New Orleans 1986; Abstr 798.
26. Symonds WT, O'Connor G, Nix DE. Focus on itraconazole: a broad-spectrum antifungal agent for treatment of blastomycosis and histoplasmosis. Hosp Formul 1993;28:23-33.
27. Tucker RM, Haq Y, Denning DW, Stevens DA. Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother 1990;26:561-566.
28. Beule KD, Cauwenbergh G. Azole shows significant response in wide range or fungi. Itra very useful in histo/crypto infections. Mycol Obser 1988;81(3):4.
29. Medoff G. What is the best treatment for histoplasmosis? Infect Dis Clin Pract 1993;2(2):131.
30. Lai KK. Successful treatment of disseminated histoplasmosis with itraconazole in an AIDS patient. Infect Dis Clin Pract 1993;2(2):125-128.